Christopher Raymond
Stock Analyst at Piper Sandler
(3.61)
Main Sectors:
42 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ARDX Ardelyx | Maintains: Neutral | 8 9 | 5.54 | 62.45% | 9 | Aug 6, 2025 | |
ABVX Abivax | Maintains: Overweight | 42 70 | 82.84 | -15.5% | 2 | Jul 23, 2025 | |
BIIB Biogen | Maintains: Neutral | 135 115 | 137.37 | -16.28% | 17 | Apr 29, 2025 | |
ALXO ALX Oncology Holding... | Maintains: Overweight | 8 9 | 1.87 | 381.28% | 6 | Mar 6, 2025 | |
BMRN Biomarin Pharmaceuti... | Maintains: Overweight | 122 126 | 53.85 | 133.98% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 4 | 1.89 | 111.64% | 3 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 220 227 | 220.68 | 2.86% | 12 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 109 119 | n/a | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 535 533 | 385.74 | 38.18% | 8 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 1195 1013 | 563.9 | 79.64% | 7 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 135 140 | 29.08 | 381.43% | 5 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 43 30 | n/a | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 76.63 | -6.04% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 3 13 | 1.99 | 553.27% | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 75 | 6.55 | 1045.04% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 66 76 | 15 | 406.67% | 7 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 10 10 | 1.58 | 532.91% | 2 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 33 | 12.97 | 154.43% | 1 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 7 | 3.25 | 115.38% | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 621 35 | n/a | n/a | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 18 23 | n/a | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 4 | n/a | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 | 14.16 | 55.37% | 1 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 2 4 | 2.74 | 45.99% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 17 | n/a | n/a | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 26 25 | 8.18 | 205.62% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 293 288 | 272.98 | 5.5% | 11 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 41 | 38.93 | 5.32% | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 1 | n/a | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 6 2 | n/a | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 28 | 42.47 | -34.07% | 1 | Jul 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 40 12 | n/a | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 56 28 | n/a | n/a | 4 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 146 180 | n/a | n/a | 2 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 40 | 81.39 | -50.85% | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 90 | 6.15 | 1363.41% | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | n/a | n/a | n/a | 3 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 35 | n/a | n/a | 1 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | n/a | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 96 | 2.48 | 3770.97% | 2 | Mar 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 170 | n/a | n/a | 1 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 133 | n/a | n/a | 2 | Oct 23, 2017 |